Since SREBP-1c has been implicated to play a role in HCC, a longer treatment of kisspeptin will reveal whether kisspeptin/KISS1R signaling can downregulate SREBP-1c levels in advanced disease and HCC. The gene discussed is KISS1; the disease is hepatocellular carcinoma.